Semaglutide Better Than Liraglutide for Post-Bariatric Surgery Weight Recurrence

WEDNESDAY, June 7, 2023 (HealthDay News) -- Semaglutide is associated with superior weight loss for treating post-metabolic and bariatric surgery (MBS) weight recurrence compared with liraglutide, according to a study published in the May issue of Obesity.
Natia Murvelashvili, M.D., from UT Southwestern Medical Center in Dallas, and colleagues compared the effectiveness of weekly semaglutide versus daily liraglutide for treating post-MBS weight recurrence in a retrospective study. The analysis included 207 adults with post-MBS weight recurrence treated with weekly semaglutide (115 individuals) or daily liraglutide (92 individuals).
The researchers report that the least-squares mean weight change at 12 months was −12.92 percent in the semaglutide group versus −8.77 percent in the liraglutide group. The odds of ≥10 and ≥15 percent weight loss over 12 months were higher in the semaglutide group versus the liraglutide group (adjusted odds ratios, 2.34 and 2.55, respectively). There were no differences seen in the effectiveness of semaglutide versus liraglutide by the subgroups analyzed, including age, sex, and bariatric procedure type.
"A strength of this study is that these real-world data reflect weight-loss outcomes achieved under circumstances of everyday clinical care in a population seeking treatment for post-MBS weight recurrence," the authors write.
Several authors disclosed ties to pharmaceutical companies, including Novo Nordisk, the manufacturer of semaglutide.
Related Posts
CMV Seropositivity Tied to Cortical Surface Area in Schizophrenia
FRIDAY, June 17, 2022 (HealthDay News) -- For adults with schizophrenia spectrum...
Could the Mediterranean Diet Help People With MS?
THURSDAY, March 2, 2023 (HealthDay News) -- A Mediterranean diet may help...
More Steps Per Day May Cut Risk for Incident Diabetes in Seniors
THURSDAY, Jan. 27, 2022 (HealthDay News) -- More steps per day are associated...
For Women Delaying Childbirth, Freezing Eggs May Be Best Option: Study
WEDNESDAY, June 1, 2022 (HealthDay News) -- Not every woman is ready to become a...